1 - 7 of 7 articles
When growing drug problems give rise to new sources of funding that in turn attract fledgling or expanding treatment facilities, it would stand to reason that regulators' capacity to oversee these operations should grow as well. State officials in Pennsylvania say they have struggled to keep up,...
The White House budget request for fiscal year 2021 for the Substance Abuse and Mental Health Services Administration (SAMHSA) proposes to zero out a major prevention program — the Strategic Prevention Framework State Incentive Grant — Partnerships for Success program. This is a cut of $109...
A very important insurance‐based retrospective study shows clearly what the clinical trials have already shown: Agonist treatment for opioid use disorder (OUD) is better than abstinence‐based or antagonist‐based treatment in terms of reducing overdose and opioid‐related morbidity. (Buprenorphine...
A pilot study published in the Journal of Addiction Medicine last month paves the way for more clinical investigations of an application developed by Emocha Health. We talked to the CEO, Sebastian Seiguer, and to the primary investigator and lead author of the study, Judith Tsui, M.D., M.P.H.,...
We attended day 1 of a lively New York Society of Addiction Medicine (NYSAM) meeting Feb. 7 and came away with the clear impression that addiction medicine physicians in New York are split when it comes to cannabis to treat substance use disorder, but wholeheartedly in favor of harm‐reduction...
The 2020 symposium of the American College of Medical Toxicology will be held March 12 in New York City (the theme is “Opioid Epidemic: Controversies and Creative Solutions”). For more information, go to https://www.acmt.net/2020Symposium.html.
Clayton Stafford died after using Vivitrol, and his family is suing Alkermes, the manufacturer, saying that the medication doesn't adequately treat addiction, compared to buprenorphine and methadone, and that the manufacturer knew this. In the lawsuit, California‐based law firm Lieff Cabraser...
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.